Correlation Between Day One and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Day One and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Day One and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Virpax Pharmaceuticals.
Diversification Opportunities for Day One and Virpax Pharmaceuticals
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Day and Virpax is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Day One i.e., Day One and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Day One and Virpax Pharmaceuticals
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.28 times more return on investment than Virpax Pharmaceuticals. However, Day One Biopharmaceuticals is 3.62 times less risky than Virpax Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 1,212 in Day One Biopharmaceuticals on September 14, 2024 and sell it today you would earn a total of 63.00 from holding Day One Biopharmaceuticals or generate 5.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Day One Biopharmaceu |
| Virpax Pharmaceuticals |
Day One and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Virpax Pharmaceuticals
The main advantage of trading using opposite Day One and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Virpax Pharmaceuticals vs. Puma Biotechnology | Virpax Pharmaceuticals vs. Iovance Biotherapeutics | Virpax Pharmaceuticals vs. Day One Biopharmaceuticals | Virpax Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |